Immune Control's Unattributed VC Round

Immune Control raised a round of funding on April 07, 2008.

Immune Control is an early-stage drug discovery company that has developed novel approaches to immune modulation using small molecule, serotonin antagonists. Merged with Arginetix to form Corridor …

Articles about Immune Control's Unattributed VC Round: